asherbio.comHealthcareFounded: 2019Funding to Date: $166.65MM
Asher Bio is a biotech company developing precisely targeted immunotherapies for cancer and other diseases.
For more details on financing and valuation for Asher Biotherapeutics, register or login.
View Enterprise Value for Asher Biotherapeutics.
To read this article and more news on Asher Biotherapeutics, register or login.